Pristanic acid

Cat. No.: HY-113024 Purity: 99.91%: FAQs
Data Sheet SDS COA Handling Instructions

Molarity Calculator

Pristanic acid is an endogenous metabolite present in Blood that can be used for the research of Alpha Methylacyl CoA Racemase Deficiency and Zellweger Syndrome.

For research use only. We do not sell to patients.

Pristanic acid Chemical Structure

CAS No. : 1189-37-3

Size	Price	Stock	Quantity
1 mg	USD 125	In-stock	Estimated Time of Arrival: December 31
5 mg	USD 320	In-stock	Estimated Time of Arrival: December 31
10 mg	USD 510	In-stock	Estimated Time of Arrival: December 31
50 mg		Get quote
100 mg		Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description

Pristanic acid is an endogenous metabolite present in Blood that can be used for the research of Alpha Methylacyl CoA Racemase Deficiency and Zellweger Syndrome^[1]^[2]^[3].

IC₅₀ & Target

Human Endogenous Metabolite

In Vitro

Endogenous metabolites is defined as those that are annotated by Kyoto Encyclopedia of Genes and Genomes as substrates or products of the ~1900 metabolic enzymes encoded in our genome. It is clear in the body of literature that there are documented toxic properties for many of these metabolites^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Molecular Weight

298.50

Formula

C₁₉H₃₈O₂

CAS No.

1189-37-3

Appearance

Liquid (Density: 0.882±0.06 g/cm³)

Color

Colorless to light yellow

SMILES

CC(C)CCCC(C)CCCC(C)CCCC(C)C(O)=O

Structure Classification

Ketones, Aldehydes, Acids

Initial Source

Microorganisms

Endogenous metabolite

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Pure form	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Solvent & Solubility

In Vitro:

DMSO : 50 mg/mL (167.50 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	3.3501 mL	16.7504 mL	33.5008 mL
5 mM	0.6700 mL	3.3501 mL	6.7002 mL
10 mM	0.3350 mL	1.6750 mL	3.3501 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Calculation results:

Working solution concentration: mg/mL

Purity & Documentation

Purity: 99.91%

Select Batch:

Data Sheet (266 KB) SDS (545 KB)

COA (238 KB) HNMR (245 KB) RP-HPLC (245 KB) MS (82 KB)

Handling Instructions (2659 KB)

References

[1]. Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39(35):5709-5720. [Content Brief]

[2]. McLean BN, et al. A new defect of peroxisomal function involving pristanic acid: a case report. J Neurol Neurosurg Psychiatry. 2002 Mar;72(3):396-9. [Content Brief]

[3]. Baumgartner MR, et al. Clinical approach to inherited peroxisomal disorders: a series of 27 patients. Ann Neurol. 1998 Nov;44(5):720-30. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	3.3501 mL	16.7504 mL	33.5008 mL	83.7521 mL
	5 mM	0.6700 mL	3.3501 mL	6.7002 mL	16.7504 mL
	10 mM	0.3350 mL	1.6750 mL	3.3501 mL	8.3752 mL
	15 mM	0.2233 mL	1.1167 mL	2.2334 mL	5.5835 mL
	20 mM	0.1675 mL	0.8375 mL	1.6750 mL	4.1876 mL
	25 mM	0.1340 mL	0.6700 mL	1.3400 mL	3.3501 mL
	30 mM	0.1117 mL	0.5583 mL	1.1167 mL	2.7917 mL
	40 mM	0.0838 mL	0.4188 mL	0.8375 mL	2.0938 mL
	50 mM	0.0670 mL	0.3350 mL	0.6700 mL	1.6750 mL
	60 mM	0.0558 mL	0.2792 mL	0.5583 mL	1.3959 mL
	80 mM	0.0419 mL	0.2094 mL	0.4188 mL	1.0469 mL
	100 mM	0.0335 mL	0.1675 mL	0.3350 mL	0.8375 mL

Pristanic acid Related Classifications

Metabolic Disease

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Pristanic acid1189-37-3Endogenous MetaboliteInhibitorinhibitorinhibit

Your Recently Viewed Products:

Product Name

Salutation

Applicant Name *

Email Address *

Phone Number *

Organization Name *

Department *

Requested quantity *

Country or Region *

Remarks